Eagle Bay Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
TIM
Eagle Bay Advisors's PFE Position: Q1 2025 in Review
Eagle Bay Advisors sold out of Pfizer (PFE) in Q1 2025, closing a stake of 6,603 shares — an estimated $175K sold.
Eagle Bay Advisors first reported a position in PFE in Q2 2021 and held it in 15 quarters. The position peaked at $643K in Q2 2022. 2,930 funds tracked by Wall St. Rank hold PFE as of Q1 2025.
- Eagle Bay Advisors reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
- Eagle Bay Advisors sold 6,603 Pfizer shares in Q1 2025, an estimated $175K.
- Eagle Bay Advisors first reported a position in Pfizer in Q2 2021 and held it in 15 quarters.
- Eagle Bay Advisors's Pfizer position peaked at $643K in Q2 2022.
- 2,930 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.
Based on Eagle Bay Advisors's 13F filing for Q1 2025, filed 5 May 2025.